Control of hemorrhage following cardiopulmonary bypass.
D000614:Aminocaproates / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D001830:Body Surface Area; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D005112:Extracorporeal Circulation / Q000009:adverse effects*; D005341:Fibrinolysin; D006470:Hemorrhage / Q000517:prevention & control*; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D011183:Postoperative Complications; D011479:Protamines / Q000008:administration & dosage; D013997:Time Factors
D000614:Aminocaproates; D011479:Protamines; D006493:Heparin; D005341:Fibrinolysin